Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003488204 | SCV004235995 | uncertain significance | not provided | 2023-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003488204 | SCV004679903 | benign | not provided | 2023-06-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004364891 | SCV005001863 | uncertain significance | Inborn genetic diseases | 2024-05-30 | criteria provided, single submitter | clinical testing | The c.1828C>T (p.L610F) alteration is located in exon 14 (coding exon 14) of the PIEZO1 gene. This alteration results from a C to T substitution at nucleotide position 1828, causing the leucine (L) at amino acid position 610 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |